ISPO

Genetic Cofactors

Oncogene activation: an informative marker for the HPV-lesions severity

C Bernard, C Mougin, R Laurent, M Lab

Gene expressions and activities of protein phosphatases 1, 2a and 2c in hepatocarcinogenesis and regeneration after partial hepatectomy

K Kikuchi, Y Mizuno, K Kitamura, Y Kakinoki, K Nakamura, S Matsuzawa, M Saadat

Complement gene expression in brain, a proinflammatory role during neurodegeneration and abnormal cell proliferation

Pasinetti, GM, Oda, T, CE Finch

Neuroblastomas presenting in the first year of life: epidemiological differences from those presenting at older ages

Niels LT Carlsen, MD,

P53 tumour suppressor gene a genetic link between heavy smoking and drinking in squamous cell carcinoma of the head and neck

JK Field, JR Gosney DA Spandidos, A Jones

Multiple mechanisms to regulate the activity of the transcription factor Jun

M Schorpp, T Oehler, I Herr, B Hagmeyer, P Angel

Genetic polymorphism of the human cyplal gene

G Cosma PhD, E Taioli MD, F Crofts BS, P Toniolo MD, S Garte PhD

Familial risk of breast cancer and abortion

N Andrieu, F Clavel, B Gairard, L Piana, A Bremond, J Lansac, R Flamant, R Renaud

A possible role of human papillomaviruses and C-MYC, C-HA-RAS and P53 gene alterations in malignant cutaneous lesions from grafted patients

I Pelisson, C Soler, S Euvrard, Y Chardonnet, D Schmitt

Alterations of ornithine decarboxylase gene during the progression of rat liver carcinogenesis

RM Pascale, MM Simile, MA Seddaiu, L Daino, HA Vinci, G Pinna, P Zolo, F Feo F

Factors influencing drug metabolizing enzymes in patients with bronchial carcinoma

C Bluhm, D Greschuchna